SiNtx Technologies Inc (SINT)

[boston745]

Together with a strategic partner, we have initiated biomechanical testing of our solid silicon nitride femoral heads. This testing is expected to continue through 2016. If the tests indicate that silicon nitride femoral heads are superior in terms of wear performance, taper corrosion, strength and in vitro hydrothermal stability, we eventually intend to commercialize this product in cooperation with a strategic partner.

The only evidence of a product being created with a strategic partner is a hip implant with Biomet, a Zimmer Biomet company. I have often used Zimmer and ZB to represent Zimmer Biomet as i see Zimmer Biomet as just a continuation of Zimmer. However legally these are 3 different entities with Zimmer and Biomet being child corporations of Zimmer Biomet Holdings. A strategic partnership with one is a strategic partnership with all imo.

You have Sintx MC2 femoral head articulating against Biomet's E1 liner. You have Si3N4 coating on Biomets G7 shell. Whats left to disclose for this product to move forward is how the femoral stem will be made. Will it be made of a metal material with coating or will it be made of a 3D printed porous Si3N4? I lean toward 3D printed porous stem because, as disclosed in a recent presentation, there is renewed interest in Sintx femoral head and coating tech for a shell after disclosure of further refining of 3d printing. As the studies made to date only indicate a product in development with Biomet IP, that really only leaves 1 company as a possible source for this renewed interest...Zimmer Biomet family of companies.

Anyone that completely ignores or disregards the information is not to be trusted. Anyone that uses legal loopholes to misrepresent connections between companies is not to be trusted. The information laid out is extensively sourced and left for the reader to decide. I would love help in further refining the information ive presented so its as accurate as possible, sadly no one is interested in truth...at least publicly. The only interest ive seen is using a small truth to drive a very different narrative that seems to distract from this truth. Stockprices can be manipulated by a cabal of persons (persons being individuals and companies). Theses business dealings cannot. They either are or are not. In this particular case, the dealings go back 17 years at least on the R&D front and go back to the beginning of Sintx on the personnel side of things.

Large companies use small companies to derisk technology and acquire it. Thats the simplest most straightforward explanation. However as shown by Eli Lilly strategic partnership with Amylin, reality is not always as straightforward. Still while Eli Lilly did not acquire Amylin in the end, it used Amylin for its benefit. Thats what i expect Zimmer Biomet to do with Sintx, for it to use Sintx for its benefit. It was a Win/Win for Eli/Amylin stakeholders and I expect that here too.


========================================

Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.

https://www.mdpi.com/2571-6131/4/2/16/htm

========================================

Electromagnetic fields, metal implant corrosion, and dis-ease it causes


https://i.imgur.com/nLg7SXT.jpg

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=172932779